News
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...
A phase 1 open-label trial is underway, evaluating the safety and efficacy of CT-95 in patients with mesothelin-expressing ...
Publisher Shiro Unlimited and Barotrauma developer FakeFish have announced Frostrail, an open-world survival first-person shooter set in a frozen world. It will launch in Early Access for PC via ...
The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...
The recommendation was based on results from the Phase III THOR trial, which compared Balversa to chemotherapy.
Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.
Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.
Coupling reactions are among the most transformative tools in organic chemistry, enabling the formation of crucial chemical ...
The FDA has approved Opdivo plus Yervoy for the first-line treatment of MSI-H/dMMR colorectal cancer, supported by the Phase ...
Explore the impact of functional respiratory tests on outcomes in anti-CD19 CAR T-cell therapy, presented at EBMT 2025.
Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective ...
The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results